Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Leutero 50 mg Injection
Manufacturer/Marketed By : Hetero Healthcare Ltd
$2.83 $0.78
Leutero 50 mg Injection is a vital therapeutic agent designed to mitigate the harmful effects of chemotherapy drugs like methotrexate and to manage cases of overdose involving anticancer medications. This...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Calcium Leucovorin 50 mg
Active Pharmaceutical Ingredient
Leutero 50 mg Injection
2.83$
0.78$
Leutero 50 mg Injection is a vital therapeutic agent designed to mitigate the harmful effects of chemotherapy drugs like methotrexate and to manage cases of overdose involving anticancer medications. This formulation, containing Calcium Leucovorin, is particularly effective in treating megaloblastic anemia that arises from folic acid deficiency, especially when oral administration isn't feasible. In addition, Leutero 50 mg Injection is often utilized in conjunction with 5-fluorouracil to enhance treatment outcomes for advanced colorectal cancer. It’s important to note that while Leutero serves as a protective and supportive treatment, patients should be closely monitored for potential side effects, especially if they have underlying health conditions. Healthcare providers will assess the risks and benefits of using this injection in conjunction with other therapies. With its multifaceted applications, Leutero stands out as a key component in oncological care, providing both protective benefits and therapeutic support. Always consult a healthcare professional before initiating treatment to ensure the best course of action tailored to individual health needs.
Active Pharmaceutical Ingredient
Uses
• Leutero 50 mg injection is primarily utilized as a rescue therapy following high-dose methotrexate treatment. This medication helps protect normal cells from the harmful effects associated with high levels of methotrexate. By administering Leutero 50 mg injection, healthcare providers aim to mitigate potential long-term complications, including damage to the liver and kidneys. This use is critical in ensuring patient safety during intensive chemotherapy regimens.
• Another important application of Leutero 50 mg injection is in the management of megaloblastic anemia. This condition, characterized by a deficiency in folic acid, leads to a reduced number of red blood cells, resulting in symptoms such as fatigue and pale skin. Leutero 50 mg injection serves to replenish folate levels, thereby addressing the underlying cause of this type of anemia. Patients receiving this treatment often experience an improvement in their overall energy levels and well-being.
• Leutero 50 mg injection is also indicated in the treatment of colorectal cancer, which affects the colon or rectum. This medication is part of a therapeutic strategy aimed at enhancing the effectiveness of cancer treatments. By using Leutero 50 mg injection, oncologists can help improve patient outcomes and quality of life during cancer therapy. Its role in managing side effects associated with chemotherapy makes it a valuable option for patients facing this diagnosis.
• In cases of folic acid antagonist overdose, Leutero 50 mg injection acts as a countermeasure to reduce toxicity. Overdosing on medications that inhibit folic acid can lead to serious health complications. Administering Leutero 50 mg injection helps to mitigate these adverse effects, thereby protecting patients from potential harm. This function underscores the importance of Leutero 50 mg injection in emergency medical situations related to medication mismanagement.
Benefits
ILeutero 50 mg in 1 Vial can reduce serious blood cell disorder symptoms like anemia, neutropenia, and thrombocytopenia, which occur as a side effect of some drugs like methotrexate, pyrimethamine, and trimethoprim. Leutero 50 mg Injection can help to decrease the side effects of chemotherapy drugs, such as nausea, vomiting, and diarrhea, by protecting normal cells from the toxic effects of chemotherapy. Leutero 50 mg may help to increase the effectiveness of chemotherapy drugs by allowing them to work more effectively against cancer. ILeutero 50 mg in 1 Vial can help to improve the quality of life for cancer patients by reducing the side effects of chemotherapy and potentially increasing the effectiveness of cancer treatment.
Side Effects
Like all medications, Leucovorin Calcium Injection can cause side effects, but they do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Nausea
• Urticaria
• Sleeplessness
• Uneasiness
• Fever
• Redness
• Abdominal pain
• Diarrhoea
• Vomiting
Common Side Effects
• Breathing difficulty
• Dizziness
• Severe allergic reaction
• Swelling all over the body
How To Use
Leutero 50 mg Injection is given intravenously (IV) or intramuscularly (IM) and administered by a healthcare professional in a hospital or clinic setting. The specific dosing and administration of ILeutero 50 mg in 1 Vial will depend on the clinical condition of the patient's age and medical history and other factors. It is important to follow your doctor's instructions carefully when using this medication.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Leucovorin Calcium Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Leutero 50 mg Injection and report any unusual symptoms or changes in kidney function to their physician. The dose of Leutero 50 mg Injection should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Calcium Leucovorin 50 mg. Leutero 50 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Leucovorin Calcium Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Leutero 50 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Leutero 50 mg Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Leutero 50 mg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Leutero 50 mg Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Leutero 50 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Leutero 50 mg Injection is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Leutero 50 mg, such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.